Dr. Boccia on Managing Adverse Events With CAR T-Cell TherapyByRalph Boccia, MDNovember 16th 2018Ralph Boccia, MD, an oncologist at the Center for Cancer and Blood Disorders, associate clinical professor at Georgetown University, discusses managing adverse events associated with chimeric antigen receptor T-cell therapy.